This site is intended for healthcare professionals only
LoginRegister

Strides Pharma Science successfully concludes WHO inspection at Puducherry facility

Ruchika SharmaWritten by Ruchika Sharma   |  
Strides Pharma Science successfully concludes WHO inspection at Puducherry facility

Bengaluru: Strides Pharma Science Limited has announced that the company has successfully completed the inspection carried out by the World Health Organization (WHO) at its Puducherry facility.The inspection was held between 16-20 January 2023. The Puducherry facility caters to the U.S., Other Regulated Markets, and Institutional businesses and can produce finished dosage...

Bengaluru: Strides Pharma Science Limited has announced that the company has successfully completed the inspection carried out by the World Health Organization (WHO) at its Puducherry facility.

The inspection was held between 16-20 January 2023.

The Puducherry facility caters to the U.S., Other Regulated Markets, and Institutional businesses and can produce finished dosage formulation products across multiple dosage formats.

Medical Dialogues team had earlier reported that the company had successfully concluded the EU GMP inspection carried out by the National Institute of Pharmacy and Nutrition (OGYÉI), Hungry at its Puducherry facility.

Read also: Strides Pharma successfully completes EU GMP inspection of Puducherry facility

Strides, a global pharmaceutical company headquartered in Bengaluru, India, is listed on the BSE and National Stock Exchange of India Limited (STAR). The Company mainly operates in the regulated markets and has an "in Africa for Africa" strategy and an institutional business to service donor-funded markets. The Company's global manufacturing sites are located in India (Chennai, Puducherry, and two locations in Bengaluru), Singapore, Italy (Milan), Kenya (Nairobi), and the United States (New York). 
Read also: Strides Pharma Science biologics arm gets USFDA EIR for Bengaluru facility




strides pharma science strides pharma news WHO WHO inspection world health organisation 
Ruchika Sharma
Ruchika Sharma

    M.Com

    Ruchika joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND
    X
    X